AMD

View as Grid List

Sort by

Display per page

Picture of 4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (2 mg)

HAD-95-0002

4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (2 mg)

Precursor for [¹¹C]MAD

Picture of 4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (5 mg)

HAD-95-0005

4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (5 mg)

Precursor for [¹¹C]MAD

Picture of 4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (50 mg)

HAD-95-0050

4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (50 mg)

Precursor for [¹¹C]MAD

Picture of 4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (Custom Volume)

HAD-95-000X

4-Methoxy-2,5-di-[10-Methyl-1,4,7,10-tetraaza cyclododecane -1,4,7-tricarboxylic acid tri-tert-butyl ester]phenol (Custom Volume)

Precursor for [¹¹C]MAD

Picture of AMD (10 mg)

AMD-95-0010

AMD (10 mg)

Intermediate of a drug with high selectivity against HIV-infected cells

Picture of AMD (2 mg)

AMD-95-0002

AMD (2 mg)

Intermediate of a drug with high selectivity against HIV-infected cells